Sangamo Therapeutics
SGMO
#5302
Rank
$0.60 B
Marketcap
$3.67
Share price
3.09%
Change (1 day)
-35.50%
Change (1 year)

P/S ratio for Sangamo Therapeutics (SGMO)

P/S ratio as of February 2023 (TTM): 5.37

According to Sangamo Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.36736. At the end of 2022 the company had a P/S ratio of 6.85.

P/S ratio history for Sangamo Therapeutics from 2001 to 2022

PS ratio at the end of each year

Year P/S ratio Change
20226.85-30.64%
20219.87-47.15%
202018.797.06%
20199.48-31.78%
201813.9-63.36%
201737.9241.21%
201611.1-31.62%
201516.2-29.06%
201422.9-36.08%
201335.8143.29%
201214.71.97%
201114.4-0.28%
201014.520.63%
200912.036.26%
20088.81-84.73%
200757.796.7%
200629.3-40.88%
200549.6-56.97%
2004115117.86%
200352.9208.67%
200217.1-63.37%
200146.8

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.51-16.04%๐Ÿ‡บ๐Ÿ‡ธ USA
5.00-6.85%๐Ÿ‡บ๐Ÿ‡ธ USA
4.00-25.56%๐Ÿ‡บ๐Ÿ‡ธ USA
0.7113-86.75%๐Ÿ‡บ๐Ÿ‡ธ USA
3.76-29.91%๐Ÿ‡บ๐Ÿ‡ธ USA
4.45-17.13%๐Ÿ‡บ๐Ÿ‡ธ USA
29.4 448.04%๐Ÿ‡บ๐Ÿ‡ธ USA
10.4 94.55%๐Ÿ‡บ๐Ÿ‡ธ USA